Inovio: INOVIO to Present at Upcoming Scientific Conferences

In This Article: PLYMOUTH MEETING, Pa. , April 9, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it will highlight key data associated with its lead candidate, INO-3107, at several upcoming conferences, including an opportunity to join other leading voices at the inaugural National HPV Conference. INOVIO will also discuss its novel DNA-encoded monoclonal antibody technology at a preconference workshop at the World Vaccine Congress. (PRNewsfoto/INOVIO Pharmaceuticals, Inc.) National HPV Conference ( Indianapolis, IN ) April 15 : Oral presentation: DNA Immunotherapy (INO-3107) Results in a 72% Overall Response Rate in Year 1 for Treatment of Recurrent Respiratory Papillomatosis Caused by HPV-6 & 11 Panel: Recurrent Respiratory Papillomatosis: Lessons Learned, Clinical Advances and Patient Experiences - Moderated by Kim McClellan , RRP Foundation President World Vaccine Congress ( Washington, DC ) April 21 : Oral presentation: A New Frontier in mAb Therapeutics: DNA-Encoded Monoclonal Antibodies (DMAb ) as Next Gen DNA Medicine April 23 : Oral presentation: DNA Immunotherapeutics in the Treatment of Cancers and Virally-Mediated Diseases Festival of Biologics ( San Diego, CA ) April 23 : Oral presentation: Advancing DNA Medicine: INO-3107 for Recurrent Respiratory Papillomatosis Available abstracts will be shared on INOVIO's website following presentations. About INOVIO INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com . Contacts Media: Jennie Willson , (267) 429-8567, communications@inovio.com Investors: Peter Vozzo - ICR Healthcare, (443) 213-0505, investor.relations@inovio.com Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/inovio-to-present-at-upcoming-scientific-conferences-302424147.html SOURCE INOVIO Pharmaceuticals, Inc. (PRNewsfoto/INOVIO Pharmaceuticals, Inc.) Cision